Shalom Haggiag

11PUBLICATIONS
23CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Cellular nervous systemApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis.

Elisa Petruccioli, Luca Prosperini, Serena Ruggieri

|Feb 26, 2025
Spinal Cord Infarction: Clinical and Neuroradiological Clues of a Rare Stroke Subtype.

Marialuisa Zedde, Arturo De Falco, Carla Zanferrari

|Oct 10, 2024
Transient vertical diplopia following ibuprofen intake: a case report.

Shalom Haggiag, Luca Prosperini, Federico Sadun

|Aug 29, 2024
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.

Alessandra Aiello, Serena Ruggieri, Assunta Navarra

|Aug 28, 2024
Concomitant Parenchymal, Subarachnoid, and Ventricular Neurocysticercosis in Rome, Italy: A Case Report with a 4-Year Follow-Up.

Maria Letizia Giancola, Shalom Haggiag, Angela Corpolongo

|May 27, 2023
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.

Serena Ruggieri, Alessandra Aiello, Carla Tortorella

Pageof 2

Frequent Collaborators

5 joint publications

Luca Prosperini

3 joint publications

Claudio Gasperini

3 joint publications

Delia Goletti

3 joint publications

Emanuele Nicastri